Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.

Article  Google Scholar 

Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.

CAS  Article  Google Scholar 

Kimura Y, Yamamoto R, Shinzawa M, Isaka Y, Iseki K, Yamagata K, et al. Alcohol consumption and incidence of proteinuria: a retrospective cohort study. Clin Exp Nephrol. 2018;22:1133–42.

Article  Google Scholar 

Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961–2009). Circulation. 2013;128:1198–205.

Article  Google Scholar 

Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43:1344–51.

CAS  Article  Google Scholar 

Kanno A, Kikuya M, Ohkubo T, Hashimoto T, Satoh M, Hirose T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transpl. 2012;27:3218–23.

CAS  Article  Google Scholar 

Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998;158:998–1004.

CAS  Article  Google Scholar 

Williams ME. The goal of blood pressure control for prevention of early diabetic microvascular complications. Curr Diab Rep. 2011;11:323–9.

Article  Google Scholar 

Tsushita K, Hosler S, Miura K, Ito Y, Fukuda T, Kitamura A, et al. Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J Atheroscler Thromb. 2018;25:308–22.

Article  Google Scholar 

Japanese Ministry of Health, Labour and Welfare. Standardized Guidelines for Specific Health Check-ups and Specific Health Guidance (2013) https://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/kenkou/seikatsu/dl/hoken-program1.pdf Accessed 29 March 2022.

Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32–8.

Article  Google Scholar 

Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.

CAS  Article  Google Scholar 

Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28:1150–6.

CAS  Article  Google Scholar 

Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage. J Hum Hypertens. 2014;28:74–9.

CAS  Article  Google Scholar 

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes. 2006;55:1832–9.

CAS  Article  Google Scholar 

Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, et al. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28:1023–39.

CAS  Article  Google Scholar 

Wang M, Li J, Li Y, Yao S, Zhao M, Wang C, et al. The effects of hypertension and diabetes on new-onset chronic kidney disease: a prospective cohort study. J Clin Hypertens (Greenwich). 2020;22:39–46.

Article  Google Scholar 

Wang Z, do Carmo JM, Aberdein N, Zhou X, Williams JM, da Silva AA, et al. Synergistic interaction of hypertension and diabetes in promoting kidney injury and the role of endoplasmic reticulum stress. Hypertension. 2017;69:879–91.

CAS  Article  Google Scholar 

Ramirez SP, McClellan W, Port FK, Hsu SI. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol. 2002;13:1907–17.

Article  Google Scholar 

Suzuki Y, Kaneko H, Okada A, Itoh H, Fujiu K, Michihata N, et al. Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline. Am J Cardiol. 2022;168:83–89.

Article  Google Scholar 

Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: Significance, pathophysiology and therapeutic implications. Am J Kidney Dis. 1999;34:973–95.

CAS  Article  Google Scholar 

Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20:390–5.

Article  Google Scholar 

Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375–82.

CAS  Article  Google Scholar 

Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, et al. Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int. 2002;62:1791–8.

Article  Google Scholar 

Ji H, Zheng W, Menini S, Pesce C, Kim J, Wu X, et al. Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production. Gend Med. 2007;4:56–71.

Article  Google Scholar 

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–100.

Article  Google Scholar 

Japanese Ministry of Health, Labour and Welfare. The implementation status of Specific Health Check-ups and Specific Health Guidance in 2013. https://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/xls/info03_h25_04.xls Accessed 29 March 2022.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: Global dimension and perspectives. Lancet 2013;382:260–72.

Article  Google Scholar 

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet 2015;385:1975–82.

Article  Google Scholar 

Liyanage T, Toyama T, Hockham C, Ninomiya T, Perkovic V, Woodward M, et al. Prevalence of chronic kidney disease in Asia: A systematic review and analysis. BMJ Glob Health. 2022;7:e007525.

Article  Google Scholar 

NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021;398:957–80.

Article  Google Scholar 

IDF DIABETES ATLAS 10th edition. Brussels: International Diabetes Federation; 2021. https://diabetesatlas.org/data/en/ Accessed 17 August 2022.